C

Cresco Labs Inc
CNSX:CL

Watchlist Manager
Cresco Labs Inc
CNSX:CL
Watchlist
Price: 0.82 CAD 10.81%
Market Cap: 280.6m CAD

Operating Margin
Cresco Labs Inc

13.1%
Current
10%
Average
6.5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.1%
=
Operating Profit
92.6m
/
Revenue
705.8m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Cresco Labs Inc
CNSX:CL
280.6m CAD
13%
US
Eli Lilly and Co
NYSE:LLY
751.2B USD
40%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
381.4B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK
45%
CH
Roche Holding AG
SIX:ROG
208.2B CHF
33%
CH
Novartis AG
SIX:NOVN
194.7B CHF
33%
UK
AstraZeneca PLC
LSE:AZN
164.9B GBP
24%
US
Merck & Co Inc
NYSE:MRK
212.8B USD
34%
IE
Endo International PLC
LSE:0Y5F
184.8B USD
11%
US
Pfizer Inc
NYSE:PFE
147.8B USD
27%

Cresco Labs Inc
Glance View

Market Cap
280.6m CAD
Industry
Pharmaceuticals

Cresco Labs Inc. engages in the business of cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. The company is headquartered in Chicago, Illinois and currently employs 3,500 full-time employees. The company went IPO on 2018-12-03. The firm is the wholesaler of branded cannabis products in the United States. Its brands include Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, the Company’s national dispensary brand, is a wellness-focused retailer. The firm operates in and/ or has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, Arizona, New York, Massachusetts, Michigan and Florida.

CL Intrinsic Value
5.58 CAD
Undervaluation 85%
Intrinsic Value
Price
C
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.1%
=
Operating Profit
92.6m
/
Revenue
705.8m
What is the Operating Margin of Cresco Labs Inc?

Based on Cresco Labs Inc's most recent financial statements, the company has Operating Margin of 13.1%.

Back to Top